1. Efficacy and safety of the biosimilar ABP 501 compared with adalimumab in patients with moderate to severe rheumatoid arthritis: a randomised, double-blind, phase III equivalence study. Issue 10 (5th June 2017) Authors: Cohen, Stanley; Genovese, Mark C; Choy, Ernest; Perez-Ruiz, Fernando; Matsumoto, Alan; Pavelka, Karel; Pablos, Jose L; Rizzo, Warren; Hrycaj, Pawel; Zhang, Nan; Shergy, William; Kaur, Primal Journal: Annals of the rheumatic diseases Issue: Volume 76:Issue 10(2017) Page Start: 1679 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Humoral immune response to vaccines in patients with rheumatoid arthritis treated with tocilizumab: results of a randomised controlled trial (VISARA). Issue 5 (21st January 2014) Authors: Bingham, Clifton O; Rizzo, Warren; Kivitz, Alan; Hassanali, Azra; Upmanyu, Ruchi; Klearman, Micki Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 5(2015) Page Start: 818 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗